slides · global inventory
Quote
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 10,645
Current window 2,911-2,940
Pages 355
Rows per page 30
Component
2,911-2,940 of 10,645
337
Uses direct quotes from an investigator to undermine the credibility of clinical trial data.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
341
The slide uses direct quotes from an expert consultation to undermine the product's value proposition.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
342
The slide uses a Q&A format to highlight the expert's negative sentiment toward the drug's efficacy and the company's investor materials.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
343
The slide presents a direct challenge to the commercial viability of 'Vykat' by highlighting a physician's preference for a cheaper, off-label alternative.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
346
The slide uses highlighted text to emphasize critical quotes from medical experts.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
356
The slide uses a Q&A transcript format to highlight low adoption rates and physician skepticism.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
357
The slide uses a 'villain' narrative by framing a specific researcher (Jennifer Miller) and patient families as a 'cult' driving artificial demand.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
360
The slide uses a summary headline followed by a verbatim quote with key phrases highlighted in yellow.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
362
The slide uses direct quotes from a pediatric endocrinologist to highlight concerns about the clinical management of diabetes risk associated with the drug.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
368
The slide highlights the physician's skepticism and the administrative hurdles faced with the drug Vykat.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
370
The slide uses a Q&A format to expose that the drug's popularity is manufactured by advocacy groups rather than medical demand.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
373
The slide uses direct quotes to frame the expert's skepticism and clinical concerns about the drug's safety profile.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
378
The slide uses a 'before-after' narrative structure to expose the contradiction between the physician's initial interest and his clinical assessment.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
380
The slide uses direct quotes to expose the contradiction between the physician's knowledge of drug inefficacy and their continued prescription behavior.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
381
The slide uses direct quotes from an expert consultation to contrast grassroots patient enthusiasm with professional indifference.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
383
The slide presents a quote from an anonymous pediatric endocrinologist criticizing Dr. Miller's influence and medical recommendations.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
394
The slide uses expert interview transcripts to undermine the value proposition of the drug Vykat.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
399
The slide uses direct quotes from an expert consultation to illustrate market resistance.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
400
The slide uses a combination of summary bullet points and verbatim Q&A transcripts to highlight the expert's negative assessment.Soleno Therapeutics (SLNO) · Scorpion Capital
Activist deck Short seller 2 hits
04
The slide uses quotes to build a narrative of corporate malfeasance and systemic gaming of organ allocation processes.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Testimonials from Industry Experts2 hits
20
The slide uses strong, emotive language ('greedy', 'predatory', 'hate') to frame the company as a villain in the transplant market.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Critique of TransMedics Group Inc.2 hits
26
Uses direct quotes from industry experts to build a case of systemic exploitation.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Exposure of Contradictions2 hits
30
The slide uses highlighted text to emphasize key quotes from an industry executive regarding systemic abuse of the cost-based reimbursement model.TransMedics (TMDX) · Scorpion Capital
Research note Short seller Beat · Exposure of Contradictions2 hits
31
The slide uses direct quotes from an industry executive to build a bearish case against TransMedics.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
60
The slide uses direct quotes to build a case for anticompetitive behavior, specifically focusing on the forced bundling of procurement services with product usage.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
62
The slide uses direct quotes from industry experts to frame the company's pricing as predatory and its leadership as arrogant.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
64
The slide uses direct quotes from MGH staff to argue that TransMedics' business model is built on control rather than efficiency.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
81
The slide uses a combination of summary text and a direct, highlighted quote from a UCSF administrator to substantiate claims of fraudulent billing.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
82
The slide uses direct quotes from interviews to highlight a lack of oversight and forced vendor usage.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits
84
The slide uses a Q&A format to highlight skepticism about TransMedics' billing practices.TransMedics (TMDX) · Scorpion Capital
Research note Short seller 2 hits